https://sputnikglobe.com/20221005/russian-health-ministry-registers-first-domestic-anti-smallpox-drug-1101543882.html
Russian Health Ministry Registers First Domestic Anti-Smallpox Drug
Russian Health Ministry Registers First Domestic Anti-Smallpox Drug
Sputnik International
MOSCOW (Sputnik) - The Russian Health Ministry registered NIOCH-14, the first domestic drug against smallpox, developed by the Vector research center... 05.10.2022, Sputnik International
2022-10-05T15:19+0000
2022-10-05T15:19+0000
2022-10-05T15:19+0000
russia
russia
smallpox
https://cdn1.img.sputnikglobe.com/img/07e6/05/12/1095613482_0:194:3000:1882_1920x0_80_0_0_6dd2cd83e8cba1c7f848fc805a108809.jpg
NIOCH-14 can be used to treat monkeypox patients, it says.After being introduced into medical practice, NIOCH-14 will be effective against any types of orthopoxviruses, which include the monkeypox virus, Sergey Shchelkunov, chief researcher at Vector's department of genomic research, said earlier.
russia
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2022
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
https://cdn1.img.sputnikglobe.com/img/07e6/05/12/1095613482_190:0:2826:1977_1920x0_80_0_0_53fbfe1c2f058541cba0ffea31c20f8c.jpgSputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
russia, smallpox
Russian Health Ministry Registers First Domestic Anti-Smallpox Drug
MOSCOW (Sputnik) - The Russian Health Ministry registered NIOCH-14, the first domestic drug against smallpox, developed by the Vector research center, according to the state register of medicines.
"Trade name: NIOCH-14. Date of state registration 04.10.2022," the document says.
NIOCH-14 can be used to treat monkeypox patients, it says.
After being introduced into medical practice, NIOCH-14 will be effective against any types of orthopoxviruses, which include the monkeypox virus, Sergey Shchelkunov, chief researcher at Vector's department of genomic research, said earlier.